Co-targeting Mitochondrial Ca2+ Homeostasis and Autophagy Enhances Cancer Cells' Chemosensitivity

Charlotte Dubois1, Artem Kondratskyi1, Gabriel Bidaux2

  • 1Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, 59000 Lille, France.

Iscience
|June 26, 2020
PubMed

Insights

Mitochondrial calcium overload alone does not induce cell death; it requires autophagy inhibition. This combination primes cancer cells for chemotherapy, offering new therapeutic strategies for cancer treatment.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Oncology

Background:

  • Mitochondria play a crucial role in cell death regulation.
  • Mitochondrial calcium (Ca2+) overload is a known inducer of apoptosis.
  • Autophagy acts as a pro-survival mechanism that can counteract cell death signals.

Purpose of the Study:

  • To investigate the interplay between mitochondrial Ca2+ overload and autophagy in cell death induction.
  • To explore the potential of modulating this pathway for enhancing chemotherapy efficacy in cancer.

Main Methods:

  • Studied the effects of mitochondrial Ca2+ overload and autophagy inhibition on cell death.
  • Investigated mitochondrial dynamics, depolarization, and cytochrome c release.
  • Assessed the impact of this combined condition on cancer cell sensitivity to various chemotherapies.

Main Results:

  • Mitochondrial Ca2+ overload alone is insufficient to induce significant cell death.
  • Concomitant inhibition of autophagy is required to enable Ca2+-induced apoptosis.
  • This combination leads to DRP1-mediated mitochondrial remodeling, depolarization, and cytochrome c release.
  • Mitochondrial Ca2+ status and autophagy modulation sensitize cancer cells to chemotherapy.

Conclusions:

  • The link between mitochondrial Ca2+ overload and apoptosis is dependent on autophagy inhibition.
  • This pathway can be therapeutically targeted to enhance chemotherapy effectiveness in various cancer types.
  • Findings redefine a key cell signaling pathway and suggest novel combination therapies for cancers and other diseases involving mitochondrial Ca2+ homeostasis.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K